Mirum Pharmaceuticals, Inc. Balance Sheet
MIRM / Health Care|8 years of annual SEC 10-K data (FY2018-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
Mirum Pharmaceuticals, Inc. had $843M in total assets and $315M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $296.7M | $222.5M | $286.3M | $28.0M | $31.3M | $142.1M | $12.0M | $52.0M |
| Accounts Receivable | $123.3M | $78.3M | $68.0M | $24.0M | $3.3M | $0 | - | - |
| Inventory | $24.9M | $22.4M | $22.3M | $5.6M | $1.5M | $0 | - | - |
| Current Assets | $549.7M | $392.8M | $387.5M | $190.2M | $166.6M | $236.3M | $119.4M | $52.0M |
| PP&E (Net) | $1.9M | $1.1M | $706.0K | $914.0K | $981.0K | $1.3M | $1.4M | $0 |
| Total Assets | $842.8M | $670.8M | $646.6M | $352.9M | $294.7M | $240.9M | $146.7M | $52.0M |
| Current Liabilities | $205.8M | $126.6M | $87.1M | $64.7M | $42.6M | $18.5M | $13.1M | $2.4M |
| Shareholders' Equity | $314.7M | $225.6M | $248.7M | $142.0M | $120.2M | $172.1M | $130.3M | -$17.3M |